Nuclear Medicine
CAPSUBAC
Name:
Capsubac-Sodium Iodide (131I)
Active Principle:
Sodium Iodide (131I)
Therapeutic Action:
It is indicated for the treatment of hyperthyroidism and in special cases of thyroid carcinoma. This medicine is for therapeutic use in:
– Graves’ disease, single or multiple diffuse toxic multinodular goiter or autonomous thyroid nodules.
– For the treatment of papillary and follicular carcinoma of the thyroid, including recurrent metastatic disease after surgery. Sodium iodide (131I) treatment is often associated with surgery and antithyroid drugs.
Nuclear Medicine
CAPSUBAC
Name:
Capsubac-Sodium Iodide (131I)
Active Principle:
Sodium Iodide (131I)
Therapeutic Action:
It is indicated for the treatment of hyperthyroidism and in special cases of thyroid carcinoma. This medicine is for therapeutic use in:
– Graves’ disease, single or multiple diffuse toxic multinodular goiter or autonomous thyroid nodules.
– For the treatment of papillary and follicular carcinoma of the thyroid, including recurrent metastatic disease after surgery. Sodium iodide (131I) treatment is often associated with surgery and antithyroid drugs.
RELATED PRODUCTS
-
123I MIBG BACON (R&D)
123I MIBG BACON (R&D)It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest... -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas... -
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test.